All reagents and solvents were obtained from commercial suppliers and were used without further purification unless otherwise stated. Purification was carried out according to standard laboratory methods.
.05 g, 6.44 mL). The mixture was stirred for 5 min at room temperature before addition of NaHB(OAc) 3 (1.4 eq., 70 mmol, 15 g). The resulting reaction mixture was then stirred for 1.5 h before quenching with saturated NaHCO 3 solution (50 mL) and extracting with CH 2 Cl 2 (3 x 50 mL). The organic extracts were combined, dried (Na 2 SO 4 ), filtered, and concentrated in vacuo to afford the title compound as a pale yellow oil (10.6 g, 100%). 
(S)-1-Phenyl-N-((furan-2-yl)methyl)ethanamine, (S)-7 5
Ph N H
Me

O
To a solution of furan-2-carboxaldehyde (50 mmol, 4.8 g, 4.14 mL) in dry Et 2 O (100 mL) at 0 °C under nitrogen was added MgSO 4 (5 g). The mixture was stirred for 5 min before addition of (S)-1-phenylethylamine (S)-5 (50 mmol, 6.05 g, 6.44 mL) and MgSO 4 (5 g). The mixture was stirred for 1 h at 0 °C before warming to room temperature and stirring for 18 h. The solid was removed by filtration and the filtrate was concentrated in vacuo to afford the crude imine 
(S)-1-Phenyl-N-((pyrrol-2-yl)methyl)ethanamine, (S)-8 4
Me
HN
To a solution of pyrrole-2-carboxaldehyde (50 mmol, 4.75 g) in dry Et 2 O (100 mL) at 0 °C under nitrogen was added MgSO 4 (5 g). The mixture was stirred for 5 min before addition of (S)-1-phenylethylamine (S)-5 (50 mmol, 6.05 g, 6.44 mL) and MgSO 4 (5 g). The mixture was stirred for 1 h at 0 °C before warming to room temperature and stirring for 18 h. The solid was removed by filtration and the filtrate was concentrated in vacuo to afford the crude imine product that was used without further purification (9.9 g, 50 mmol, 100% [α] D 23 (R): +47.9 (c 1.5, CHCl 3 ). 
N-((R)-1-Phenylethyl)-2-(piperidin-1-yl)acetamide, (R)-10
Ph N H Me N O A solution of (R)-1-phenylethylamine (R)-
Ethyl 2-(N-morpholino)acetate
2-(4-Methylpiperazin-1-yl)-N-((R)-1-phenylethyl)acetamide, (R)-12
A solution of (R)-5 (28.7 mmol, 3.48 g, 3.7 mL) and ethyl 2-(4-methylpiperazin-1-yl)acetate (28.7 mmol, 5.35 g) in Et 2 O (60 mL) was treated with NaH (60% dispersion in mineral oil, 1.2 eq., 31.6 mmol, 1.26 g). The resultant mixture was refluxed for 18 h before cooling to room temperature and quenching with H 2 O (30 mL). The mixture was extracted with Et 2 O (3 x 50 mL) and the organic extracts were combined, dried (Na 2 SO 4 ), and filtered before concentrating to a residue that was purified by column chromatography (Et 2 O) to afford the title compound as a white solid (4.73 g, 63% [α] D 23 (R): +37.7 (c 1.5, CHCl 3 ). [α] D 23 (R): +35.3 (c 1.5, CHCl 3 ). Methylpiperazin-1-yl) 
(R)-1-Phenyl-N-(2-(piperidine-1-yl)ethyl)ethanamine, (R)-13
(R)-N-(2-(N-Morpholino)ethyl)-1-phenylethanamine, (R)-14
(R)-N-2-((4-
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